HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 7, Pages 2263
Publisher
MDPI AG
Online
2020-03-26
DOI
10.3390/ijms21072263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Prognostic and Therapeutic Value of PD-L1 in Glioma
- (2019) Ruo Qiao Chen et al. Frontiers in Pharmacology
- In vivo conversion of astrocytes to oligodendrocyte lineage cells in adult mice demyelinated brains by Sox2
- (2019) Sahar Farhangi et al. Multiple Sclerosis and Related Disorders
- Molecular responses to immune checkpoint blockade in glioblastoma
- (2019) Hirotaka Ito et al. NATURE MEDICINE
- Targeting cholesterol metabolism in glioblastoma: a new therapeutic approach in cancer therapy
- (2019) Leila Pirmoradi et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Overexpression of oncostatin M receptor regulates local immune response in glioblastoma
- (2019) Qing Guo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efficiently Targeting Metastatic Osteosarcoma, Neuroblastoma and Glioblastoma with Ex-Vivo Expanded Natural Killer Cells Combined with N-803 (ALT-803, IL-15 Superagonist) and TIM-3 Blockage
- (2019) Yaya Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Neuropathological and genomic characterization of glioblastoma‐induced rat model: How similar is it to humans for targeted therapy?
- (2019) Farzaneh Sharifzad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma
- (2019) Bahram Mirani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Competition for nutrients and its role in controlling immune responses
- (2019) Nidhi Kedia-Mehta et al. Nature Communications
- Simvastatin Increases Temozolomide‐induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes
- (2019) Shahla Shojaei et al. FEBS Journal
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- Immune Microenvironment in Glioblastoma Subtypes
- (2018) Zhihong Chen et al. Frontiers in Immunology
- Statins: a new approach to combat temozolomide chemoresistance in glioblastoma
- (2018) Shahla Shojaei et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Immune cells track hard-to-target brain tumours
- (2018) Neeha Zaidi et al. NATURE
- Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant
- (2018) Sandra M. Cardona et al. Frontiers in Cellular Neuroscience
- The Broad Spectrum of Human Natural Killer Cell Diversity
- (2017) Aharon G. Freud et al. IMMUNITY
- Dovitinib enhances temozolomide efficacy in glioblastoma cells
- (2017) Thatchawan Thanasupawat et al. Molecular Oncology
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Overcoming the blood–brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system
- (2017) Wei Shi et al. RSC Advances
- Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells
- (2017) Javad Alizadeh et al. Scientific Reports
- A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
- (2017) Fadi Kandarian et al. Jove-Journal of Visualized Experiments
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- Fast free-of-acrylamide clearing tissue (FACT)—an optimized new protocol for rapid, high-resolution imaging of three-dimensional brain tissue
- (2017) Na Xu et al. Scientific Reports
- Tumor infiltrating immune cells in gliomas and meningiomas
- (2016) Patrícia Domingues et al. BRAIN BEHAVIOR AND IMMUNITY
- Targeting Hsp70: A possible therapy for cancer
- (2016) Sanjay Kumar et al. CANCER LETTERS
- CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
- (2016) Laura Hertwig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
- (2016) Laura Garros-Regulez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tumor treating fields: a novel treatment modality and its use in brain tumors
- (2016) Andreas F. Hottinger et al. NEURO-ONCOLOGY
- NK cells activated by Interleukin-4 in cooperation with Interleukin-15 exhibit distinctive characteristics
- (2016) Tsuyoshi Kiniwa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HSP70-based anti-cancer immunotherapy
- (2016) Irina V. Guzhova et al. Human Vaccines & Immunotherapeutics
- NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
- (2015) Erik Ames et al. JOURNAL OF IMMUNOLOGY
- Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation
- (2015) Kangan Li et al. Nanomedicine
- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- Role of membrane Hsp70 in radiation sensitivity of tumor cells
- (2015) Naoya Murakami et al. Radiation Oncology
- Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
- (2015) Hanno M. Specht et al. Frontiers in Immunology
- Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
- (2015) Sabrina Genßler et al. OncoImmunology
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
- (2013) Silvina B. Nadin et al. CELL STRESS & CHAPERONES
- Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update
- (2012) Daniel R. Ciocca et al. ARCHIVES OF TOXICOLOGY
- MRI-Monitored Transcatheter Intra-Arterial Delivery of SPIO-Labeled Natural Killer Cells to Hepatocellular Carcinoma
- (2012) Alexander Y. Sheu et al. INVESTIGATIVE RADIOLOGY
- Whole Animal Perfusion Fixation for Rodents
- (2012) Gregory J. Gage et al. Jove-Journal of Visualized Experiments
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- The killer's kiss: the many functions of NK cell immunological synapses
- (2008) Konrad Krzewski et al. CURRENT OPINION IN CELL BIOLOGY
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
- (2008) G. Minniti et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started